Earnings
Keros Therapeutics Inc
KROS · NASDAQ13.49
13.49
USD-0.08-0.59%Historical EPS
Q1 20
Q2 20
Q3 20
Q4 20
Q1 21
Q2 21
Q3 21
Q4 21
Q1 22
Q2 22
Q3 22
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
Earnings
Q1 20
Q2 20
Q3 20
Q4 20
Q1 21
Q2 21
Q3 21
Q4 21
Q1 22
Q2 22
Q3 22
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Q1 25
EPS Estimate
-1.37
-1.35
-1.23
-1.28
-0.43
0.01
EPS Actual
-1.34
-1.21
-1.25
-1.41
-1.14
3.62
EPS Difference
0.03
0.14
-0.02
-0.13
-0.71
3.61
Surprise %
2.19%
10.37%
-1.63%
-10.16%
-166.98%
48166.67%
Annual EPS
EPS Actual
Date
EPS Actual
Stock Price
31/03/2025
3.62
10.19
31/12/2024
-5.01
15.83
31/12/2023
-5.20
39.76
31/12/2022
-4.15
48.02
31/12/2021
-2.52
58.51
31/12/2020
-6.82
70.54
Q3 21
Sep 30’ 21
4-0.72-0.81-0.64-0.60-0.20%
4-----
-0.72-0.72-0.70-0.72-0.72
010-
Q4 21
Dec 31’ 21
4-0.79-0.81-0.77-0.73-0.07%
425K25K25K--
-0.79-0.79-0.79-0.79-0.77
000-
Q1 22
Mar 31’ 22
4-0.86-1.08-0.34-0.68-0.26%
36M-18M--
-0.86-0.86-0.86-0.86-0.86
000-
Q2 22
Jun 30’ 22
5-1.06-1.13-1.00-0.67-0.58%
5-----
-1.06-1.07-1.07-1.07-1.11
000-
Q3 22
Sep 30’ 22
6-1.23-1.32-1.09-0.87-0.41%
6-----
-1.23-1.23-1.23-1.23-1.12
000-
Q4 22
Dec 31’ 22
7-1.04-1.07-1.01-0.63-0.65%
7215K-1.5M--0.96%
-1.04-1.04-1.04-1.04-1.04
000-
Q1 23
Mar 31’ 23
7-1.12-1.23-1.05-1.01-0.11%
6220K-1.3M--
-1.12-1.12-1.12-1.09-1.10
000-
Q2 23
Jun 30’ 23
9-1.34-1.43-1.22-1.13-0.19%
8160K-1.3M--
-1.34-1.35-1.34-1.35-1.30
000-
Q3 23
Sep 30’ 23
9-1.35-1.46-1.27-0.92-0.47%
9-----
-1.35-1.35-1.35-1.35-1.38
000-
Q4 23
Dec 31’ 23
11-1.31-1.35-1.27-1.04-0.26%
11--2.5K--
-1.31-1.31-1.31-1.31-1.31
010-
Q1 24
Mar 31’ 24
10-1.35-1.62-1.20-1.26-0.07%
8-----
-1.35-1.35-1.35-1.34-1.35
000-
Q2 24
Jun 30’ 24
10-1.23-1.43-1.10-1.270.03%
9-----
-1.23-1.23-1.23-1.24-1.29
000-
Q3 24
Sep 30’ 24
15-1.28-1.47-1.11-1.330.04%
12-----
-1.28-1.28-1.27-1.27-1.26
001-
Q4 24
Dec 31’ 24
10-1.03-1.380.08-1.300.21%
138M25K52.6M-211.25%
-1.03-1.03-1.03-1.05-1.33
000-
Q1 25
Mar 31’ 25
Previous qtr.
80.01-1.353.60-1.211.01% 1156.6M-210M-681.48%
0.010.160.34-1.35-1.37
220-
Q2 25
Jun 30’ 25
Current qtr.
7-1.15-1.30-0.88-1.250.08% 113.8M-20M-102.52%
-1.15-1.15-1.13-1.10-1.10
112-
Q3 25
Sep 30’ 25
7-1.03-1.35-0.74-1.410.27%
112.9M-19M-6.52%
-1.03-1.03-1.04-0.98-0.90
112-
Q4 25
Dec 31’ 25
60.09-0.150.33-1.251.08%
1055.2M52.8M67.1M-61.21%
0.090.090.07-0.80-0.60
060-
Q4 26
Dec 31’ 26
8-1.02-1.52-0.610.09-11.85%
124.3M-24.1M--0.92%
-1.02-1.02-1.08-1.03-0.94
024-
FAQs
What is Keros Therapeutics Inc stock price today?
The current price of Keros Therapeutics Inc is 13.49 USD — it has decreased by -0.59% in the past 24 hours. Watch Keros Therapeutics Inc stock price performance more closely on the advanced chart.
What is Keros Therapeutics Inc stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Keros Therapeutics Inc stocks are traded under the ticker KROS.
Is KROS stock price going up?
KROS stock has decreased by -0.44% in the past week, has decreased by -4.53% in the past month, and has decreased by -70.29% in the past year. See more data on KROS chart.
What is the analyst recommendation for KROS?
As of 21 Jun 2025, out of 5 analyst recommendations, the majority rate KROS as a buy.
What is KROS market cap?
As of today, KROS has the market capitalization of 550.34M USD. Explore our list of stocks ranked by market cap to compare KROS with other stocks.
Does KROS release financial reports?
Yes, you can track KROS financials in yearly and quarterly reports on Profit.com.
When is KROS next earnings date?
KROS is going to release the next earnings report on -. Keep track of upcoming events with our Earnings Calendar.
What were KROS Earnings for the last quarter?
KROS reported earnings of $-1.14 per share for the last quarter, lower then the estimate of $-0.427 per share, resulting in a -166.98% surprise. The estimated earnings for the next quarter are $0.0075 per share. See more details about KROS earnings on Profit.com.
What was KROS Revenue for the last quarter?
KROS's revenue for the last quarter was 211.25M USD, higher then the estimated 2.92M USD. The estimated revenue for the next quarter is 55.21M USD See more stats in KROS financial reports on Profit.com.
What was KROS Net Income for the last quarter?
KROS net income for the last quarter is 148.45M USD, while the quarter before that showed -46.03M USD of net income which accounts for -422.54% change. See more stats in KROS financial reports on Profit.com.
Does KROS pay dividends?
No, KROS doesn't pay any dividends to its shareholders. But you can explore a list of high-dividend stocks on Profit.com.
How many employees does KROS have?
As of 21 Jun 2025, KROS employs approximately 163 employees. Check out if KROS is on our list of largest employers.
What is KROS EBITDA?
EBITDA, which measures a company's operating performance, reflects its efficiency improvements. KROS EBITDA is -9.01M USD, with a current EBITDA margin of 1.96%. See more stats in KROS financial reports on Profit.com.
How to buy KROS stocks?
Like other stocks, KROS shares are traded on stock exchanges such as NASDAQ. The easiest way to buy them is through an online stock broker. Simply open an account, follow the broker's procedures, and start trading. Alternatively, you can practice trading Tesla stock on Profit.com in Playtrade Tournaments or choose a recommended broker to trade directly.
Should I invest in KROS stock?
Investing in stocks requires thorough research, including analyzing the company’s financials, related news, and technical analysis. Currently, Tesla's technical analyst recommendations show a buy rating.
Before investing in KROS, consider subscribing to Profit PRO where can practice trading in Playtrade Tournaments, access AI-powered daily market insights, copy expertly handpicked Watchlists, and follow Billionaire Portfolios.
What are you waiting for?Start making profit today
More
Resources
Profit mobile app
Discover the world of finance in your pocket
©
2025
All rights reserved